stockrowAdagio Medical Holdings, Inc.
ADGMAdagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023.
- Revenue
- −33.5%
- EPS
- −15.4%
- Free cash flow
- −12.9%
- Total debt
- +46.6%
Quarter to June 2026, against a year earlier
Follow ADGM
Alert me
Adagio Medical Holdings, Inc. (ADGM) Return on invested capital
Adagio Medical Holdings, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −74.6%, up 9.1 percentage points from fiscal 2025 (−83.7%). Over the past ten years it has ranged from −341.5% (fiscal 2024) to 0.00% (fiscal 2023); the current reading is higher than 29% of that period. That is below the Medical Devices industry median of −5.22% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −83.7% | 257.77 |
| FY2024 | −341.5% | (341.51) |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| GCTK GlucoTrack, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| DHAI DIH Holding US, Inc. compare | 0.00% |
| ICCM IceCure Medical Ltd. compare | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc compare | −27.9% |
| ADGM Adagio Medical Holdings, Inc. | −74.6% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| NXL Nexalin Technology, Inc. compare | −1,108.8% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)